respiratori
syncyti
viru
rsv
major
caus
lower
respiratori
tract
ill
children
children
initi
rsv
infect
normal
occur
within
first
year
life
infant
less
year
age
lower
respiratori
infect
due
rsv
case
viru
fatal
sever
infect
welldefin
highrisk
group
includ
infant
histori
prematur
birth
chronic
lung
diseas
congenit
heart
diseas
cystic
fibrosi
immunodefici
highrisk
infant
palivizumab
human
monoclon
antibodi
produc
favor
result
date
strongli
recommend
administ
prophylact
howev
children
rsv
infect
previous
healthi
often
difficult
predict
deterior
rsv
infect
rsvrelat
enceph
acut
encephalopath
symptom
seizur
sever
sequela
even
death
follow
rsv
infect
children
without
underli
diseas
sporad
report
rsvrelat
enceph
usual
develop
within
day
onset
clinic
symptom
high
fever
cough
fatigu
howev
mechan
underli
rapid
progress
relat
enceph
remain
unclear
central
nervou
system
cn
infect
coinfect
bacteria
dysfunct
host
immun
system
may
possibl
caus
nextgener
sequenc
ng
accompani
metagenom
analysi
use
nonselect
method
pathogen
discoveri
increasingli
appli
diagnost
tool
investig
caus
underli
unexplain
enceph
patient
two
key
featur
methodolog
make
assumpt
type
pathogen
potenti
detect
nucleotid
speci
caus
pathogen
may
necessarili
abund
signal
ng
result
may
sometim
present
lowlevel
signal
compar
signal
associ
commens
pathogen
howev
provid
unbias
sensit
identif
report
present
case
girl
born
prematur
underli
diseas
whose
sudden
death
may
relat
rsv
infect
identifi
convent
method
metagenom
analys
viral
antigen
detect
base
immunofluoresc
assay
luminex
xtag
respiratori
viral
panel
assay
posit
rsv
patient
nasopharyng
aspir
collect
nov
day
diseas
onset
day
admiss
neg
adenoviru
influenza
b
virus
parainfluenza
viru
human
metapneumoviru
enterovirus
rhinovirus
human
coronaviru
human
bocaviru
patient
guardian
refus
consent
lumbar
punctur
cerebrospin
fluid
csf
avail
detect
cn
infect
blood
biochemistri
result
summar
tabl
amount
red
blood
cell
rbc
hemoglobin
platelet
continu
decreas
onset
symptom
extrem
high
level
creactiv
protein
third
day
mgl
suggest
viral
bacteri
infect
howev
bacteri
cultur
blood
specimen
yield
neg
result
percentag
lymphocyt
helper
cell
suppressor
cell
account
respect
ratio
proport
b
lymphocyt
nk
cell
respect
immunolog
index
indic
dysfunct
patient
immun
system
oral
swab
nasopharyng
aspir
serum
specimen
collect
nov
day
diseas
onset
day
admiss
subject
multiplex
metagenom
analys
use
ng
platform
nucleic
acid
librari
construct
previous
describ
amplifi
nucleic
acid
librari
analyz
use
illumina
hiseq
sequenc
singl
read
bp
raw
sequenc
read
filter
use
previous
describ
criteria
obtain
valid
sequenc
bacteriophag
plantorigin
sequenc
result
food
debri
oral
caviti
contamin
reagent
use
sampl
process
step
murin
leukemia
viru
mlv
exampl
exclud
human
rsv
base
ncbi
taxonomi
databas
identifi
least
one
specif
sequenc
oral
swab
read
nasopharyng
aspir
read
virusrel
sequenc
detect
serum
specimen
meanwhil
larg
number
sequenc
read
relat
bacteria
includ
streptococcu
miti
streptococcu
parasanguini
streptococcu
pneumonia
streptococcu
salivariu
streptococcu
infanti
streptococcu
sui
neisseria
meningitidi
neisseria
gonorrhoea
haemophilu
sputorum
haemophilu
parainfluenza
enterococcu
cecorum
condit
pathogen
bacteria
also
detect
oral
swab
nasopharyng
aspir
orand
serum
specimen
fig
howev
although
metagenom
analysi
show
sequenc
read
assign
kingdom
bacteria
bacteri
cultur
blood
specimen
yield
neg
result
base
random
distribut
read
rsv
viru
genom
complet
length
genom
obtain
use
ng
method
gap
amplif
rsv
strain
subtyp
rsvb
found
cluster
ba
genotyp
signatur
duplic
g
gene
newli
identifi
viru
name
full
genom
sequenc
deposit
genbank
access
number
phylogenet
analysi
conduct
repres
sequenc
nearli
rsvb
subgroup
genbank
belong
subgroup
fig
nucleotid
homolog
comparison
reveal
g
gene
strain
close
relat
share
homolog
strain
isol
child
guangzhou
china
six
import
antigen
site
ii
iv
v
vi
fusion
protein
drug
vaccin
palivizumab
target
mutat
found
rsv
infect
gener
caus
symptom
fever
cough
wheez
respiratori
failur
may
occur
sever
case
fatal
rate
high
clinic
case
patient
case
studi
infect
rsv
diseas
progress
rapidli
extens
cerebr
edema
hernia
prior
report
neurolog
complic
rsv
infect
mainli
includ
central
apnea
seizur
encephalopathi
apnea
common
occurr
rsvinfect
patient
younger
month
age
frequent
indic
intub
mechan
rsvrelat
apnea
unknown
significantli
reinforc
laryng
chemoreflex
immatur
respiratori
center
infanc
propos
evid
encephalit
patholog
caus
rsv
infect
spars
presenc
rsv
csf
detect
use
polymeras
chain
reaction
report
singl
case
boy
febril
seizur
pathogenesi
rsvrelat
enceph
yet
fulli
understood
howev
hypothes
rsv
may
enter
cn
hematogenousbloodbrain
barrier
rout
invas
caus
releas
sever
humor
neurotox
cytokin
mediat
diseas
consid
cours
treatment
includ
follow
sever
hand
foot
mouth
diseas
usual
caus
enteroviru
type
diseas
sudden
onset
case
symptom
includ
fever
rash
herp
appear
oral
mucosa
hand
feet
diseas
progress
quickli
small
number
case
especi
children
younger
year
old
day
onset
complic
mening
enceph
encephalomyel
pulmonari
edema
circulatori
disord
occur
small
number
infect
worsen
lead
death
howev
symptom
herp
pulmonari
edema
observ
patient
viral
pathogen
analys
show
neg
result
enterovirus
specul
support
high
pathogen
influenza
viru
infect
typic
symptom
includ
fever
cough
sore
throat
headach
bodi
pain
fatigu
patient
progress
quickli
sever
pneumonia
acut
respiratori
distress
syndrom
ard
shock
acut
necrot
brain
injuri
howev
child
underw
repeat
influenza
viru
antigen
detect
result
neg
thu
specul
support
fulmin
myocard
initi
symptom
primarili
includ
fever
cough
fatigu
vomit
diseas
develop
rapidli
lead
sudden
congest
heart
failur
cardiogen
shock
adamstrok
syndrom
ecg
sometim
demonstr
stt
chang
myocardi
infarct
arrhythmia
cardiac
ultrasound
may
show
left
ventricular
enlarg
howev
abnorm
observ
ecg
heart
ultrasound
analys
patient
thu
specul
support
patient
guardian
refus
consent
lumbar
punctur
csf
specimen
avail
valid
could
sure
whether
neuroinvas
rsv
occur
case
rsv
rare
identifi
cn
specimen
find
somewhat
similar
influenza
enceph
britton
et
al
describ
case
influenzaassoci
neurolog
diseas
without
test
influenza
virus
csf
specimen
whether
influenza
viru
invad
cn
still
controversi
fujimoto
et
al
report
influenza
viru
rna
detect
csf
patient
develop
influenzaassoci
acut
encephalopathyenceph
howev
report
small
number
patient
posit
viral
rna
csf
brain
lack
inflamm
brain
tissu
fatal
case
report
case
influenza
rna
detect
csf
howev
find
exclud
influenza
caus
enceph
viral
rna
may
clear
time
csf
taken
fact
rna
longer
detect
exclud
earlier
cn
insult
viru
caus
current
symptom
case
report
although
direct
evid
rsv
infect
cn
avail
clinic
symptom
togeth
laboratori
find
metagenom
analysi
result
suggest
patient
may
sever
sepsi
potenti
result
rsv
infect
high
probabl
cn
infect
acut
neurolog
complic
combin
ng
metagenom
analysi
provid
import
clinic
tool
identifi
unexpect
novel
pathogen
patient
advantag
methodolog
maxim
caus
pathogen
present
lowlevel
signal
compar
signal
repres
environment
commens
pathogen
improv
optim
implement
protocol
suitabl
clinic
sampl
doubt
improv
microbi
diagnosi
clinic
practic
find
conjunct
previous
report
case
emphas
need
awar
neurolog
complic
rsv
infect
clinic
manifest
may
includ
seizur
encephalopathi
focal
neurolog
find
earli
recognit
neurolog
complic
rsv
infect
import
initi
effect
treatment
reduc
mortal
longterm
morbid
